Panel Discussion: Pharma 2030: Creating a future-ready, responsible and resilient sector

Panellists in this video:
+ Ms Lakshmipriya Nair, Assistant Editor, Express Pharma, The Indian Express (P) Ltd. (Moderator)
+ Mr Ravi Bhardwaj, VP-Quality, Ind-Swift
+ Mr Abhinav Vikash, GM, Sun Pharma
+ Mr Gursharanjit Singh, Unit Head- Manufacturing Operations FTO-8, Dr Reddy’s Laboratories
+ Mr Rajiv Sharma, Sr GM – Supply chain, Panacea Biotec

Key Highlights:
[1] As we move towards 2030, continuously analysing gaps and driving improvements is non-negotiable. Quality must evolve with the industry.

[2] Adopting a growth mindset, breaking down internal silos, and being open to new opportunities are essential for sustainable progress in pharma

[3] Building pharma facilities of the future requires foresight, agility and integration of emerging technologies.

[4] Data and digitalisation will be key growth drivers. Pharma players must effectively leverage them to retain global competitiveness.

[5] India Pharma Inc must identify and tap into newer geographies and lucrative market segments. What got us here won’t take us forward.

[6] Innovation should not just be a goal—it must become a core part of the pharma sector’s DNA, embedded throughout its journey.